îæ€çŽ¢
îæ€çŽ¢
î
Protagonist Therapeutics Inc
PTGXîãŠã©ãããªã¹ãã«è¿œå
136.640USD
-2.000-1.44%
çµå€Â 07-31 16:00ïŒETïŒ15åé
ãã®æ ªäŸ¡
8.79Bæ䟡ç·é¡
æ倱é¡çŽè¿12ã¶æPER
åçäºæž¬
é貚: USD æŽæ°æå»: 2026-07-31Protagonist Therapeutics Incã®çŸåšã®åçäºæž¬ã¹ã³ã¢ã¯8.57ã§ããã€ãªãã¯ãããžãŒ & å»çç 究æ¥çã§ã¯385瀟äž99äœã§ãã ç®æšæ ªäŸ¡ã®å¹³åã¯91.00ã§ãæé«ã¯115.00ãæäœã¯65.00ã§ãã
ã¢ããªã¹ãè©äŸ¡
14
人ã®ã¢ããªã¹ãäºæ³ã«åºã¥ã
è²·ã
çŸåšã®è©äŸ¡
133.538
ç®æšæ ªäŸ¡
+0.40%
äžæäœå°
匷åè²·ã
è²·ã
äžç«
売ã
匷å売ã
åæ¥ä»ç€Ÿæ¯èŒ
496
åèš
6
äžå€®å€
7
å¹³å
äŒç€Ÿå
è©äŸ¡
ã¢ããªã¹ã
Protagonist Therapeutics Inc
PTGX
14
Beigene Ltd
ONC
27
argenx SE
ARGX
26
IQVIA Holdings Inc
IQV
26
Ionis Pharmaceuticals Inc
IONS
25
Insmed Inc
INSM
23
1
2
3
...
99
ãµããŒãã©ã€ã³ãšã¬ãžã¹ã¿ã³ã¹ã©ã€ã³
äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
財åäºæž¬
EPS
åç
çŽå©ç
EBIT
äºæž¬å€
å®çžŸå€
ãããã質å
Protagonist Therapeutics Inc ã®æ¬¡ã®ååæã®åçã¯ãããã§ãã?
îProtagonist Therapeutics Inc ã®äºæ³åç㯠203.76M ã§ãã
Protagonist Therapeutics Inc ã®ç®æšæ ªäŸ¡ã¯ãããã§ãã?
îã¢ããªã¹ãã¯ãProtagonist Therapeutics Inc ã®ç®æšæ ªäŸ¡ã USD 91.00 ãšäºæ³ããæé«äºæ³ã¯ USD 115.00ãæäœäºæ³ã¯ USD 65.00 ãšäºæ³ããŠããŸãã
Protagonist Therapeutics IncPTGX ã®æè¿ã® 1 æ ªåœããã®å©çã¯ã©ããªã£ãŠããŸãã?
îåžå Žäºæ³ã¯ USD 0.06 ã§ããããProtagonist Therapeutics IncPTGX ã®åååæã®äžæ ªåœããå©ç (EPS) 㯠USD -0.69 ã§ããã次ã®ååæã® EPS 㯠USD 2.08 ãšäºæ³ãããŸãã
Protagonist Therapeutics Inc ã«å¯Ÿããã¢ããªã¹ãã®è©äŸ¡ã¯äœã§ãã?
î14 ã¢ããªã¹ãã«ãã Protagonist Therapeutics Inc æ ªã®è©äŸ¡ã«åºã¥ããšãã»ãšãã©ã®ã¢ããªã¹ã㯠買ã ã®ãã¬ã³ããæ¯æããŠããŸããä»ã®ã¢ããªã¹ãã®æèŠãèæ
®ããçµæãæçµçã« Protagonist Therapeutics Inc ã®æ ªäŸ¡ã¯ è²·ã ãšè©äŸ¡ãããŸããããã¯ååŒã«é¢ããã¢ããã€ã¹ã§ã¯ãªãããšã«æ³šæããŠãã ããããã¯ãç¬èªã®åæãè¡ãå¿
èŠããããŸãã